Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet's disease

Int Ophthalmol. 2022 Nov;42(11):3321-3331. doi: 10.1007/s10792-022-02331-4. Epub 2022 May 27.

Abstract

Purpose: The molecules human interleukin (IL-18), the soluble cluster of differentiation (sCD40), platelet factor 4 variant 1 (PF4V1), and neutrophil gelatinase-associated lipocalin (NGAL) are all markers of inflammation in biological systems and are linked to prognosis in several inflammatory diseases as well. Since there is no study in which the above-mentioned molecules are studied together in ocular Behçet's disease (OBD), the aim of this study is to reveal whether these molecules are activity markers in active (OABD) and inactive (OIBD) disease.

Methods: 30 OABD and 30 OIBD and 30 healthy individuals were included in the study. IL-18, sCD40, PF4V1, and NGAL molecules were studied in blood samples by the ELISA method.

Results: When OABD and OIBD were compared to healthy individuals, the levels of IL-18, sCD40, PF4V1, and NGAL molecules were found to be statistically significant. These values were even more significantly higher in patients with OABD.

Conclusion: When ROC values of IL-18, sCD40, PF4V1, and NGAL are evaluated, it is clear that these four molecules can be used as biomarkers to aid activity and diagnosis in OBD.

Keywords: Interleukin; Neutrophil gelatinase-associated lipocalin; Ocular Behçet’s disease; Platelet factor; Soluble cluster of differentiation.

MeSH terms

  • Behcet Syndrome* / diagnosis
  • Biomarkers
  • Humans
  • Interleukin-18*
  • Lipocalin-2
  • Platelet Factor 4

Substances

  • Lipocalin-2
  • Interleukin-18
  • Platelet Factor 4
  • Biomarkers